IQVIA

IQVIA

Yahoo Finance • yesterday

These healthcare stocks have the highest EPS revision grade ahead of Q3 results

[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images As Q3 2026 earnings season approaches, healthcare stocks are drawing investor attention as markets assess earnings e... Full story

Yahoo Finance • 3 days ago

UBS flags 56 stocks where growth and profitability may be underpriced

[Hands holding up columns of bar graph] We Are UBS Global Research has constructed a 56-stock basket of U.S. companies with higher forward growth, stronger cash-flow profitability and improving earnings momentum, arguing that valuations f... Full story

Yahoo Finance • 3 days ago

IQVIA Launches IQVIA Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes

RESEARCH TRIANGLE PARK, N.C., October 07, 2026--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, tod... Full story

Yahoo Finance • 5 days ago

1 S&P 500 Stock with Competitive Advantages and 2 We Turn Down

1 S&P 500 Stock with Competitive Advantages and 2 We Turn Down The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn't mean every stock is worth owning. Some companies face significant challenges, whether... Full story

Yahoo Finance • 18 days ago

Pharmacovigilance Software Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)

Company Logo The global pharmacovigilance software market is projected to grow from USD 4.5 billion in 2026 to USD 12.7 billion by 2036, at a 10.9% CAGR. Growth is driven by stricter drug safety regulations, expanding clinical trials, ris... Full story

Yahoo Finance • 24 days ago

IQVIA Stock Rises 60% in 6 Months: Here's What You Should Know

IQVIA IQV stock has surged 60.1% in the past six months. The company's shares outpaced the industry's 4.1% return and the Zacks S&P 500 Composite's 14% rally. 6-Month Share Price PerformanceZacks Investment Research Image Source: Zacks I... Full story

Yahoo Finance • 25 days ago

A Strong Rebound Case of IQVIA Holdings (IQV)

Broyhill Asset Management, a Charlotte-based firm, issued its second-quarter 2026 investor letter, which is available for download here. The Broyhill Equity Composite gained 8.8% in Q2, trailing the MSCI All Country World Index's 15.1% and... Full story

Yahoo Finance • 30 days ago

Why Is NeuroPace (NPCE) Down 0.4% Since Last Earnings Report?

It has been about a month since the last earnings report for NeuroPace, Inc. (NPCE). Shares have lost about 0.4% in that time frame, outperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings releas... Full story

Yahoo Finance • last month

IQVIA prices $2B of senior notes due 2034

IQVIA Holdings (IQV [https://seekingalpha.com/symbol/IQV]) announced on Wednesday that its wholly owned subsidiary, IQVIA, priced an offering of $2B in aggregate principal amount of senior notes due 2034. The proceeds from the notes offer... Full story

Yahoo Finance • last month

1 Profitable Stock with Solid Fundamentals and 2 That Underwhelm

1 Profitable Stock with Solid Fundamentals and 2 That Underwhelm Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn't mean it will... Full story

Yahoo Finance • last month

IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster

RESEARCH TRIANGLE PARK, N.C., September 03, 2026--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, today announced IQVIA Predictive Clinical Develo... Full story

Yahoo Finance • last month

VEEV Raises FY27 Outlook as Vault CRM and AI Momentum Accelerate Fast

Veeva Systems Inc. VEEV raised its fiscal 2027 outlook after second-quarter revenues increased 17.6% year over year to $928 million. Vault CRM adoption and broader commercial execution added another positive signal. The question is how qu... Full story

Yahoo Finance • last month

Here's Why You Should Retain IQVIA Stock in Your Portfolio Now

Shares of IQVIA IQV have had an excellent run over the past month. The stock has gained 21.7% compared with the industry and the Zacks S&P 500 Composite's growth of 9.7% and 3.5%, respectively. The company's third-quarter 2026 earnings ar... Full story

Yahoo Finance • 2 months ago

IQVIA Ranked No. 1 Pharmaceutical Technology Provider by Everest Group

RESEARCH TRIANGLE PARK, N.C., August 17, 2026--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, toda... Full story

Yahoo Finance • 2 months ago

Unpacking Q2 Earnings: Repligen (NASDAQ:RGEN) In The Context Of Other Drug Development Inputs & Services Stocks

Unpacking Q2 Earnings: Repligen (NASDAQ:RGEN) In The Context Of Other Drug Development Inputs & Services Stocks Quarterly earnings results are a good time to check in on a company's progress, especially compared to its peers in the same s... Full story

Yahoo Finance • 2 months ago

Stock futures edge lower as traders focus on Strait of Hormuz reopening

[The New York Stock Exchange on the Wall street sign] Dmitry Vinogradov Stock index futures were lower on Tuesday as traders continued to focus on developments related to the reopening of the Strait of Hormuz. Dow futures (INDU [https://... Full story

Yahoo Finance • 2 months ago

[Latest] Global Generative AI In Clinical Trials Market Size/Share Worth USD 1.86 Billion by 2035 at a 9.63% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Generative AI In Clinical Trials Market size & share revenue was valued at approximat... Full story

Yahoo Finance • 2 months ago

The Backlog Tells the Real Story: Inside IQVIA’s Blowout Q2

The global healthcare ecosystem in 2026 is leading to a strong recovery in clinical research, with global pharma R&D investment topping $250 billion and the clinical research organization (CRO) market rising to $72 billion at roughly a 9%... Full story

Yahoo Finance • 2 months ago

An IQVIA Insider Sold Just Before the Stock Slipped. Here's What Long-Term Investors Should Know

Keriann Cherofsky, an executive at IQVIA Holdings Inc. (NYSE:IQV), sold 558 shares on July 29, 2026, for a total value of about $136,827, according to an SEC Form 4 filing. Transaction summary Metric Value Transaction value ~$136,827 Sha... Full story

Yahoo Finance • 2 months ago

An IQVIA Insider Just Sold Over $1 Million in Stock. Here's What Long-Term Investors Should Know

Eric Sherbet, an executive at IQVIA Holdings Inc. (NYSE:IQV), sold 5,000 shares of common stock on July 29, 2026, according to a recent SEC Form 4 filing. Transaction summary Metric Value Transaction value ~$1.2 million Shares sold (dire... Full story